Chase Doyle

Authored Items

Simvastatin plus Vitamin D May Prevent Headaches in Adults with Migraines
Chase Doyle
Migraine
VBCN - November 2016 Volume 3, No 3
The Causes and Consequences of Misdiagnosing Multiple Sclerosis
Chase Doyle
Multiple Sclerosis
VBCN - November 2016 Volume 3, No 3
Brain–Computer Interfaces Breaking New Ground in Patients with Neurologic Disability
Chase Doyle
Brain Technology
VBCN - November 2016 Volume 3, No 3
Idalopirdine Improves Cognition in Patients with Moderate Alzheimer’s Disease
Chase Doyle
Alzheimer’s Disease/Dementia
VBCN - November 2016 Volume 3, No 3
Pro and Con: Do Cognitive-Enhancing Activities Prevent Dementia?
Chase Doyle
Alzheimer’s Disease/Dementia
VBCN - November 2016 Volume 3, No 3
Alzheimer’s Prevention Clinic: A New Approach to Disease Management Shows Benefits
Chase Doyle
Alzheimer’s Disease/Dementia
VBCN - November 2016 Volume 3, No 3
Neuro-Oncology Update for Neurologists
Chase Doyle
Neurology News
Web Exclusives
Better Care Is Less Costly; Quality Improvement Through Process Management
Chase Doyle
Health Economics
VBCN - July 2016 Volume 3, No 2
Ocrelizumab Promotes No Evidence of Disease Activity in Multiple Sclerosis
Chase Doyle
Emerging Therapies
VBCN - July 2016 Volume 3, No 2
Emerging Disease-Modifying Therapies for Multiple Sclerosis
Chase Doyle
Emerging Therapies
VBCN - July 2016 Volume 3, No 2
Dichlorphenamide Improves Outcomes in Periodic Paralysis
Chase Doyle
Emerging Therapies
VBCN - July 2016 Volume 3, No 2
Experts Debate the Benefits of Early Aggressive Therapy in Multiple Sclerosis
Chase Doyle
Multiple Sclerosis
VBCN - July 2016 Volume 3, No 2
Natalizumab Shows Significant Benefit in Slowing Disability Progression in Multiple Sclerosis
Chase Doyle
Multiple Sclerosis
VBCN - July 2016 Volume 3, No 2
Zika Virus Linked to Guillain-Barré Syndrome
Chase Doyle
Neurologic Disorders Update
VBCN - July 2016 Volume 3, No 2
Individualizing Antiepileptic Drug Therapy: Consider the Side Effects
Chase Doyle
Epilepsy
VBCN - July 2016 Volume 3, No 2
Poor Response to Acute Migraine Treatment May Lead to Headache Progression
Chase Doyle
Migraine
VBCN - July 2016 Volume 3, No 2
Magnetic Stimulation Decreases "Freezing" Episodes in Parkinson's Disease, Improves Patient Outcomes
Chase Doyle
Parkinson’s Disease
VBCN - July 2016 Volume 3, No 2
Imatinib Can Be Safely Discontinued in Patients with Deep Molecular Response
Chase Doyle
Hematologic Cancers
Web Exclusives
Inhaled Levodopa Provides Rapid Motor Improvements in Patients with Parkinson’s Disease
Chase Doyle
Parkinson’s Disease
VBCN - July 2015 Volume 2, No 2
Racial Disparities in Daily Activities After Stroke: Why Are Outcomes Worse in African Americans?
Chase Doyle
Stroke
VBCN - July 2015 Volume 2, No 2
Sodium Valproate Reduces Pain in Pediatric Patients with Migraine
Chase Doyle
Headache Management
VBCN - July 2015 Volume 2, No 2
Patient-Reported Outcomes in Secondary-Progressive Multiple Sclerosis
Chase Doyle
Multiple Sclerosis
VBCN - July 2015 Volume 2, No 2
Best Practices in Multiple Sclerosis
Chase Doyle
Multiple Sclerosis
VBCN - July 2015 Volume 2, No 2
Study Identifies Predictors of Outcomes in Patients with Mild Ischemic Stroke
Chase Doyle
Stroke
VBCN - July 2015 Volume 2, No 2
Antipsychotics Increase Mortality in Parkinson’s Disease
Chase Doyle
Parkinson’s Disease
VBCN - July 2015 Volume 2, No 2
Screening Tool Predicts Risk for Dementia in Patients with Parkinson’s Disease
Chase Doyle
Parkinson’s Disease
VBCN - July 2015 Volume 2, No 2
Increased Use of Sodium Channel Blockers May Reduce Costs in Partial-Onset Seizures
Chase Doyle
Health Economics
VBCN - July 2015 Volume 2, No 2
Parameters Affecting Treatment Decisions for Patients with Multiple Sclerosis
Chase Doyle
Health Economics
VBCN - July 2015 Volume 2, No 2
Sex Differences in Response to Tramadol Therapy
Chase Doyle
Pain Management
VBCN - July 2015 Volume 2, No 2
Unemployment Status Linked to Disability in Secondary-Progressive Multiple Sclerosis
Chase Doyle
Health Economics
VBCN - July 2015 Volume 2, No 2
New Biomarkers Identify Chronic Pain Severity
Chase Doyle
Pain Management
VBCN - July 2015 Volume 2, No 2
Opioid Abuse Risk in Patients with Chronic Pain
Chase Doyle
Pain Management
VBCN - July 2015 Volume 2, No 2
Should Neurologists Prescribe Opioids for the Management of Chronic Pain?
Chase Doyle
Pain Management
VBCN - May 2015 Volume 2, No 1
Teriflunomide Demonstrates Significant Efficacy in Patients with Multiple Sclerosis
Chase Doyle
Multiple Sclerosis
VBCN - May 2015 Volume 2, No 1
High Doses of Biotin Improve Physical, Neurologic Function in Patients with Progressive Multiple Sclerosis
Chase Doyle
Multiple Sclerosis
VBCN - May 2015 Volume 2, No 1
Nonpsychoactive Cannabidiol Helps Children with Severe Epilepsy
Chase Doyle
Epilepsy
VBCN - May 2015 Volume 2, No 1
Preventing Disease Relapse in Patients with Multiple Sclerosis May Reduce Associated Costs
Chase Doyle
Health Economics
VBCN - May 2015 Volume 2, No 1
Inpatient Care Coordination Could Impact Clinical Outcomes, Duration of Hospital Stays
Chase Doyle
Health Economics
VBCN - May 2015 Volume 2, No 1
Inpatient Costs for MS-Related Disease Relapse Higher for Males Than for Females
Chase Doyle
Health Economics
VBCN - May 2015 Volume 2, No 1
Differences in Disease Burden Examined
Chase Doyle
Parkinson’s Disease
VBCN - May 2015 Volume 2, No 1
Is the Science of Stem Cells Ready?
Chase Doyle
Clinical Trials
VBCN - May 2015 Volume 2, No 1
Should Whole-Exome Sequencing Be Integrated into Neurologic Care?
Chase Doyle
Personalized Medicine in Neurology
VBCN - May 2015 Volume 2, No 1

Subscribe to
Value-Based Care in Neurology

Stay up to date with personalized medicine by subscribing to recieve the free VBCN e‑Newsletter.

I'd like to recieve:

Sign Up for Value-Based Care in Neurology

Subscribe to receive the free, monthly VBCN e‑newsletter.

©2021 Engage Healthcare Communications, LLC. All Rights Reserved. Privacy Policy.